Below are lists of the top 10 open-market insider purchases and sales filed at the
on Monday as ranked by dollar value. Company executives and directors are in the best position to assess the attractiveness of their firms' shares, and here is how many of them are voting their wallets!
Dollar value is only one metric to assess the importance of an insider transaction, however. For more value-added tables on a weekly basis, and fundamentally researched investment ideas inspired by insiders, subscribe to
. Whether you're a growth, value, income, momentum, or microcap investor, insider data can help you find great investment ideas.
|
| Company Name (Ticker) |
Filer Name |
Title(s) |
Shares
Bought |
Dollar
Value |
| Zale (ZLC) |
Breeden Richard C |
DIR,BO |
1,000,000 |
$6,292,900 |
| Ligand Pharmaceuticals (LGND) |
BVF Partners L Pil |
BO |
1,590,600 |
$3,102,534 |
| Equinix (EQIX) |
Crosslink Capital Inc |
DIR |
40,100 |
$1,580,301 |
| Align Technology (ALGN) |
Gund Gordon |
O |
151,000 |
$1,056,502 |
| Rhi Entertainment (RHIE) |
Baupost Group LLCma |
BO |
181,400 |
$725,600 |
| Infinera (INFN) |
Balkanski Alexandre |
DIR |
60,200 |
$515,011 |
| Bruker (BRKR) |
Laukien Frank H |
CEO,PR,
DIR,BO |
200,000 |
$857,621 |
| Agilysys (AGYS) |
Cueva R Andrew |
DIR |
131,806 |
$332,664 |
| Network Equipment Tech (NWK) |
Kopp Leroy C |
BO |
100,000 |
$302,450 |
| Boulder Gr & Inc Fd (BIF) |
Ernest Horejsi Trust No 1b |
BO |
70,500 |
$297,704 |
|
|
| Company Name (Ticker) |
Filer Name |
Title(s) |
Shares
Sold |
Dollar
Value |
| Boston Scientific (BSX) |
Nicholas Peter M |
DIR |
2,148,000 |
$13,106,243 |
| Boston Scientific (BSX) |
Abele John E |
DIR |
1,274,000 |
$7,774,986 |
| Campbell Soup (CPB) |
Van Beuren Hope H |
BO |
135,680 |
$4,269,362 |
| Sei Investments (SEIC) |
West Alfred P Jr |
DIR,BO |
271,840 |
$3,977,739 |
| Southwestern Energy (SWN) |
Kerley Gregory D |
VP |
100,000 |
$3,543,000 |
| Lumber Liquidators (LL) |
Sullivan Thomas D |
CB,DIR,
BO |
281,675 |
$2,532,075 |
| Equity Residential (EQR) |
Spector Gerald A |
VCB,DIR |
75,000 |
$2,290,215 |
| Boston Scientific (BSX) |
Nicholas Peter M |
DIR |
341,000 |
$2,078,230 |
| Par Pharmaceutical (PRX) |
Flynn James E |
BO,BO |
173,500 |
$1,811,510 |
| Silgan Holdings (SLGN) |
Silver R Philip |
DIR,BO |
34,240 |
$1,527,374 |
|
Key to Titles:
A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed. |
| Source: InsiderInsights.com |